Outcome Assessment for Epilepsy Surgery:The Impact of Measuring Health-Related Quality of Life
Ann Neurol 37:158-166, 1411995., Vickrey,B.G.,et al, 1995
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Outcome Research in Neurology:Incorporating Health-Related Quality of Life
Ann Neurol 37:141-142, Devinsky,O., 1995
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Effect of a Stroke Protocol on Hospital Costs of Stroke Patients
Neurol 44:1961-1964, Bowen,J.&Yaste,C., 1994
Clinicopathologic Conference, Neurosyphilis
NEJM 386:583-590, Case 4-2022, 2022
Clinicopathological Conference, Systemic Lupus Erythematosus with Antiphospholipid Syndrome
NEJM 386:1560-1570, Case 12-2022, 2022
Clinicopathologic Conference, Ocular Syphilis
NEJM 380:1062-1071, Case 8-2019, 2019
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
A 64-year-old Woman with Subacute Encephalopathy
Neurol 85:e64-e65, Bhai, S.,et al, 2015
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Neurosyphilis
Adams & Victors Principles of Neurology, Chp 32, pg 723, Ropper, A.H.,et al, 2014
Deep-Brain Stimulation for Parkinsons Disease
NEJM 367:1529-1538, Okon, M.S., 2012
Treatment of Brain Arteriovenous Malformations
JAMA 306:2011-2019, Beijnum, J.V.,et al, 2011
Acute Stroke Therapy at the Crossroads
JAMA 306:2026-2028, Broderick, J.P. and Meyers, P.M., 2011
Clinicopath Conference: Secondary Syphilis Involving Skin and Optic Nerve (Neurosyphilis)
NEJM 363:865-874, Case 26: 2010, 2010
Recanalization Devices Should Be Restricted to Clinical Trials: Pro (Kind Of)
Stroke 41:191-193, 196, Schellinger,P. &Hacke,W., 2010
Clot Retrieval for Stroke Should Be Restricted to Clinical Trials: No
Stroke 41:194-195, 196, Furlan,A., 2010
Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004
Neurosyphillis in the Modern Era
JNNP 75:1727-1730, Timmermans,M. &Carr,J., 2004
Gene Transfer for Neurologic Disease
Neurol 63:2225-2232, Mendell,J.R. &Miller,A., 2004
Neuronal Regenration After Stroke
NEJM 348:2355-2356, Nadareishvili,Z. &Hallenbeck,J., 2003
Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002
Neurology:Then, Now, and in the Future
Arch Neurol 59:1369-1373, McKhann,G.M., 2002
Angioplasty and Stenting Should be Performed Only in the Setting of a Clinical Trial
Stroke 33:2519-2523, Brott,T.G., 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Aptiganel Hydrochloride in Acute Ischemic Stroke
JAMA 286:2673-2682,2718, Albers,G.W.,et al, 2001
Current Concepts in Mild Cognitive Impairment
Arch Neurol 58:1985-1992, Petersen,R.C.,et al, 2001
Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
JAMA 279:1298-1303, 13041998., Fisher,M.&Bogousslavsky,J., 1998
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Research Involv Subj with Dementia & Other Cognitive Impairments:NIH, & Ethical Considerations
Neurol 45:1777-1778, Wichman,A.&Sandler,A.L., 1995
Inclusion Body Myositis and Myopathies
Ann Neurol 38:705-713, Griggs,R.C.,et al, 1995
Recurrent Stroke and Thrombo-Occlusive Events in the Antiphospholipid Syndrome
Ann Neurol 38:119-124, Levine,S.R.,et al, 1995
The Response of Symptomatic Neurosyphilis to High-Dose Intravenous Penicillin G in Pts with HIV Infection
NEJM 22:1469-1473, 15161994., Gordon,S.M.,et al, 1994
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
The Results of Clinical Trials in Stroke Rehabilitation Research
Arch Neurol 50:37-44, ottenbacher,K.J.&Jannell,S., 1993
Vascular Dementia:Diagnostic Criteria for Research Studies, Report of the NINDS-AIREN Intern'l Workshop
Neurol 43:250-260, Romas,G.C.,et al, 1993
Use of Twin Cohorts for Research in Alzheimer's Disease
Neurol 43:261-267, Breitner,J.C.S.,et al, 1993
IgM Antibody to Treponema Pallidum in Cerebrospinal Fluid of Infants with Congenital Syphilis
Am J Dis Child 146:1171-1175, Sanchez,P.J.,et al, 1992
The Use of Fetal Tissue in Research on Parkinson's Disease
NEJM 327:1591-1592, Kassirer,J.P.&Angell,M., 1992
Case 32-1991:Tests for Neurosyphilis
NEJM 326:1434, Whitefield,S.G.,et al, 1992
Prevalence of Neurosyphilis in Human Immunodeficiency Virus-Infected Patients with Latent Syphilis
Am J Med 93:9-12, Holtom,P.D.,et al, 1992
Screening for Dementia and Investigating Its Causes
Ann Int Med 115:122-132, Siu,A.L., 1991
Neurosyphilis in AIDS Patients:Initial CSF VDRL May be Negative
Neurol 40:541-543, Feraru,E.R.,et al, 1990
Utility of the VDRL Test in HIV-Seropositive Patients
NEJM 322:271, Drabick,J.J.&Tramont,E.C., 1990
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987